ResearcherStanford MedicineActive in the last 2 years
Jason L. Guo
Matched on ORCID iD 0000-0002-7264-2614; OpenAlex author ID A5025739767. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116849↗
- Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116347↗
- Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. Co-author DOI 10.1089/ten.tea.2024.0039↗
- Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.xcrm.2023.101248↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deshka S. Foster · 4 shared papers, 2023–2026 · strength 0.70
- Paper NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116849↗
- Paper Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116347↗
- Paper Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. DOI 10.1089/ten.tea.2024.0039↗
- Daniel Delitto · 4 shared papers, 2023–2026 · strength 0.70
- Paper NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116849↗
- Paper Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116347↗
- Paper Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. DOI 10.1089/ten.tea.2024.0039↗
- Michael Thornton Longaker · 4 shared papers, 2023–2026 · strength 0.70
- Paper NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116849↗
- Paper Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116347↗
- Paper Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. DOI 10.1089/ten.tea.2024.0039↗
- Jeffrey Allen Norton · 4 shared papers, 2023–2026 · strength 0.70
- Paper NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116849↗
- Paper Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.116347↗
- Paper Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. DOI 10.1089/ten.tea.2024.0039↗
- George A. Poultsides · 2 shared papers, 2025–2026 · strength 0.39
- Maria Moozhiyil Korah · 2 shared papers, 2025–2026 · strength 0.39
- James Paul Agolia · 2 shared papers, 2025–2026 · strength 0.39
- Brendan Christopher Visser · 2 shared papers, 2025–2026 · strength 0.39
- Chuner Guo · 2 shared papers, 2025–2026 · strength 0.39
- Shamik Mascharak · 2 shared papers, 2023–2024 · strength 0.31
- Teri A. Longacre · 2 shared papers, 2023–2024 · strength 0.31
- Annah Grace Morgan · 1 shared paper, 2026 · strength 0.22
- Byrne Lee · 1 shared paper, 2025 · strength 0.17
- Amanda Kirane · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.